Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Chia Tai Tianqing Pharmaceutical Group Co., Ltd.)"
Count: 228
Selected: 0
NCT IDTitle
NCT05496569TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma
NCT05487976Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor
NCT05481645Efficacy and Safety of TQB2450 Combined With Chemotherapy ± Anlotinib for Advanced Endometrial Cancer
NCT05476341A Phase I Clinical Trial of Bevacizumab Injection
NCT05472324Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.
NCT05451407Efficacy and Safety of TQB2618 Injection Combined With Terriprizumab Injection in Patients With Advanced Melanoma
NCT05426798Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
NCT05416359Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors
NCT05405439To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer
NCT05400876To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Pembrolizumab in the Treatment of Patients With Relapsed and Refractory Lymphoma
NCT05380934A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects
NCT05375461TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail
NCT05365178To Evaluate the Efficacy and Safety of TQB3616 in Combination With Flulvesant Versus Placebo in Combination With Flulvesant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer
NCT05353179Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers
NCT05346952A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC).
NCT05344729Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects
NCT05340530To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult Subjects
NCT05333276Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers
NCT05292196A Phase II Clinical Trial of TQC3721 Suspension for Inhalation
NCT05284994TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer
NCT05198531To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer
NCT05154630Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors
NCT05145218A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer
NCT05121363A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma
NCT05121350A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma
NCT05110807A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors
NCT05107037A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis
NCT05068921A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy
NCT05068206A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx
NCT05051930A Clinical Trial of TQC3721 Suspension for Inhalation
NCT05046847A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors
NCT05029076Human Bioequivalence Test of Liraglutide Injection
NCT05028218A Clinical Study of TQB3824 in Subjects With Advanced Cancer
NCT05021367A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor
NCT05020652A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis
NCT05020639A Study of TQB3820 in Patients With Hematological Malignancies
NCT05011019A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis
NCT04975204A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors
NCT04964479A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)
NCT04956328Study of Obeticholic Acid(OCA) Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
NCT04955834A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes
NCT04944043A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease
NCT04941404A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)
NCT04925141A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
NCT04924192A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer
NCT04923607Phase I Clinical Trial of TQC2731 Injection
NCT04895345A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma
NCT04854681Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers
NCT04854668A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
NCT04853498A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets